Loading
Latest filing published 24 Nov 2020 for Appili Therapeutics Inc..
No signal scores available.
Jolyon Burton discloses dealings in Appili Therapeutics Inc. to SEDI. Altogether 2 filings, all relating to 13 June 2019.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 24 November 2020 with a transaction in Appili Therapeutics Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations